Standout Papers

Patient-derived xenograft (PDX) models, applications and challenges in cancer research 2022 2026 2023 2024163
  1. Patient-derived xenograft (PDX) models, applications and challenges in cancer research (2022)
    Shahrokh Abdolahi, Zeinab Ghazvinian et al. Journal of Translational Medicine

Immediate Impact

1 by Nobel laureates 59 standout
Sub-graph 1 of 24

Citing Papers

Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment
2024 Standout
Emerging nitric oxide gas‐assisted cancer photothermal treatment
2024 Standout
2 intermediate papers

Works of Samad Muhammadnejad being referenced

HeLa cell line xenograft tumor as a suitable cervical cancer model: growth kinetic characterization and immunohistochemistry array.
2014
Evaluation of antitumor activity of a TGF-beta receptor I inhibitor (SD-208) on human colon adenocarcinoma
2014

Author Peers

Author Last Decade Papers Cites
Samad Muhammadnejad 245 258 95 124 57 714
Danfeng Luo 155 317 104 154 31 627
Kaiwen Hu 176 250 64 128 74 831
Regina Miftakhova 296 351 138 88 40 829
Batoul Farran 201 418 94 182 33 809
Wenhua Zhan 182 347 104 110 40 697
Beilei Liu 254 326 144 114 20 722
Hebe Durán 116 399 99 112 39 775
Da Li 274 244 134 156 30 690
Yanru Qin 178 256 94 110 50 715
Yanyun Gao 146 330 52 113 47 810

All Works

Loading papers...

Rankless by CCL
2026